The first domestic targeted il-36r monoclonal antibody was administered to the first subject in New Zealand
According to the official account of WeChat, Shanghai, China's Limited by Share Ltd has announced that the HB0034 project, the first recombinant IL-36R monoclonal antibody against human IL-36R, has been completed in New Zealand. The phase ia clinical study conducted in New Zealand aims to evaluate the safety, tolerance, immunogenicity and pharmacokinetics of hb0034 in healthy subjects. Huaaotai biology is a subsidiary of Huahai pharmaceutical, a listed company.
This text is a result of machine translation.
Related companies：
Briefing Mar 21, 2025 05:14 PM
· Technology
Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May
In-depth
Technology
DeepSeek | China's AI Global Breakthrough and Ecosystem Restructuring
Mar 19, 2025 01:18 PM
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Briefing Sep 18, 2023 07:40 PM
· Technology
4Paradigm Initiates IPO Today and Targets HKSE on September 28
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Automotive, Technology
WeRide Signs Tripartite Agreement with Uber and Dubai's RTA
On June 15, 2025, Chinese autonomous driving technology company WeRide signed a cooperation agreement with the Dubai Roads and Transport Authority (RTA) and Uber Technologies, Inc., the world’s largest mobility and delivery tech company. The three parties will collaborate to deploy commercial Robotaxi services in Dubai.
Jun 16, 2025 02:19 PM
Automotive, Technology
EqualOcean Weekly Hotspots Series (6/8-6/13)
1.Roborock Announces Planned Hong Kong Listing; Overseas Sales Surpass Domestic Market|2.BYD: Global Expansion and Premiumization Are Key Strategies|3.Alibaba.com: Christmas Orders Surge 3 Months Ahead of Schedule |4.CHANGAN Automobile Plans 20 Overseas Plants Globally, Expanding into Over 100 Countries|5.Insta360 Debuts on the STAR Market with a 285% Surge, Market Value Exceeds CNY 70 Bn|6.CHERY to Become China’s First Automaker to Export Over 5 Mn Vehicles
Jun 13, 2025 05:48 PM
Consumer Staples, Technology
Insta360 Debuts on the STAR Market with a 285% Surge, Market Value Exceeds CNY 70 Bn
On June 11, Insta360 (stock code: 688775.SH), a leading Chinese intelligent imaging company, officially listed on the Shanghai Stock Exchange's STAR Market. According to the prospectus, the offering price was CNY 47.27 per share, corresponding to a post-IPO market value of approximately CNY 18.96 billion. On its first day of trading, the opening price was CNY 182 per share, representing a 285% increase from the offering price, with the total market value surpassing CNY 70 bn.
Jun 11, 2025 06:59 PM
Technology, Automotive
CHANGAN Automobile Plans 20 Overseas Plants Globally, Expanding into Over 100 Countries
On June 7, the 27th Chongqing International Auto Exhibition officially opened. As a leading local car manufacturer in Chongqing, CHANGAN Automobile participated under the theme "Together for A Smarter World", showcasing its full brand matrix and presenting its phased achievements and future plans in new energy, intelligence, and globalization.
Jun 10, 2025 03:05 PM
Briefing Aug 26, 2021 06:31 PM
· Healthcare
Huahai pharmaceutical: the net profit in the first half of the year was 516 million yuan, a year-on-year decrease of 10.84%
See more
Read next
Insight
In-depth
Insight
In-depth
Automotive · Analysis
$30 Million Lost Annually in the West, Yet Chinese Enterprises Pay No Attention
Apr 30, 2025 11:14 AM
Insight
In-depth
Technology · Analysis
Auto Shanghai 2025 - Nullmax Showcases Full-Stack Automated Driving Solutions
Apr 25, 2025 11:24 PM
Insight
In-depth
Technology · Analysis
SAIC MAXUS Partners with Huawei Qiankun, Multiple Models to be Launched
Apr 25, 2025 08:41 PM